Patients with neurofibromatosis 1 show neurocognitive deficits including abnormal visuospatial performance, but oculomotor behavior has not been studied. We recorded saccades in neurofibromatosis 1 and normal children, ages 6 to 12 years. Patients showed increased latency and diminished amplitude to more eccentric targets for both visually guided and memory-guided saccades. Subtracting the latencies of visually guided saccades from memory-guided saccades produced no differences between groups. For predictive saccades (0.5 Hz), patients with neurofibromatosis 1 generated fewer anticipatory saccades than normal subjects, but patients with neurofibromatosis 1 made more direction errors in an antisaccade task. Patients with neurofibromatosis 1 show saccade abnormalities that are not easily ascribed to dysfunction within single cortical areas. Rather, the findings likely reflect (1) partial involvement of different components of a widely distributed cerebral network that controls saccades, (2) impaired visuomotor maturation in a brain abnormal early in development, and (3) excessive γ-aminobutyric acid—mediated inhibition, which could influence basal ganglia pathways that modulate superior colliculus activity. (J Child Neurol 2003;18:348—355).
Get full access to this article
View all access options for this article.
References
1.
Wallace MR, Marchuk DA, Andersen LB, et al: Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science1990 ;249:181—186.
2.
Gutmann DH, Donahoe J., Brown T., et al: Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol2000;26:361—367.
3.
Ferner RE, Chaudhuri R., Bingham J., et al: MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment . J Neurol Neurosurg Psychiatry1993;56:492—495.
4.
Itoh T., Magnaldi S., White RM, et al: Neurofibromatosis type 1: The evolution of deep gray and white matter MR abnormalities. AJNR Am J Neuroradiol1994;15:1513—1519.
5.
North K., Joy P., Yuille D., et al: Specific learning disability in children with neurofibromatosis type 1: Significance of MRI abnormalities. Neurology1994;44:878—883.
6.
DeBella K., Poskitt K., Szudek J., Friedman JM: Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children. Neurology2000;54:1646—1651.
7.
Denckla MB, Hofman K., Mazzocco MM, et al: Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet1996;67:98—102.
8.
Moore BD 3, Slopis JM, Schomer D: Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology1996;46:1660—1668.
9.
Eldridge R., Denckla MB, Bien E., et al: Neurofibromatosis type 1 (Recklinghausen's disease). Am J Dis Child1989;143:833—837.
10.
Mazzocco Mmm, Turner JE, Denckla MB: Language and reading deficits associated with neurofibromatosis type 1: Evidence for a not-so-nonverbal learning disability. Dev Neuropsychol1995;11: 503—522.
11.
DuPaul GJ: Parent and teacher ratings of ADHD symptoms: Psychometric properties in a community based sample. J Clin Child Psychol1991;20:243—253.
12.
Reich MJ, Shayka T., Taibleson C.: The Diagnostic Interview for Children and Adolescents-Revised. St. Louis, Washington University, 1991.
13.
Ross RG, Radant AD, Young DA, Hommer DW: Saccadic eye movements in normal children from 8 to 15 years of age: A developmental study of visuospatial attention. J Autism Dev Disord1994;24:413—431.
14.
Munoz DP, Broughton JR, Goldring JE, Armstrong IT: Age-related performance of human subjects on saccadic eye movement tasks. Exp Brain Res1998;121:391—400.
15.
Gaymard B., Ploner CJ, Rivaud S.: Cortical control of saccades. Exp Brain Res1998;123:159—163.
16.
Pierrot-Deseilligny C., Rivaud S., Gaymard B., Agid Y.: Cortical control of reflexive visually-guided saccades. Brain1991;114: 1473—1485.
17.
Pierrot-Deseilligny CH, Ploner CJ, Muri RM, et al: Effects of cortical lesions on saccadic eye movements in humans. Ann N Y Acad Sci2002;956:216—229.
18.
Leigh RJ, Zee DS: The Neurology of Eye Movements, 3rd ed. Oxford, England, Oxford University Press, 1999.
19.
Ploner CJ, Rivaud-Pechoux S., Gaymard BM, et al: Errors of memory-guided saccades in humans with lesions of the frontal eye field and the dorsolateral prefrontal cortex. J Neurophysiol1999;82: 1086—1090.
20.
Vermersch AI , Gaymard BM, Rivaud-Pechoux S., et al: Memory guided saccade deficit after caudate nucleus lesion. J Neurol Neurosurg Psychiatry1999;66:524—527.
21.
Pierrot-Deseilligny C., Rivaud S., Gaymard B., et al: Cortical control of saccades. Ann Neurol1995;37:557—567.
22.
Gaymard B., Rivaud S., Cassarini JF, et al: Effects of anterior cingulate cortex lesions on ocular saccades in humans. Exp Brain Res1998;120:173—183.
23.
O'Driscoll GA, Wolff AV, Benkelfat C., et al: Functional neuroanatomy of smooth pursuit and predictive saccades. Neuroreport2000;11:1335—1340.
24.
Gutmann DH: Learning disabilities in neurofibromatosis 1: Sizing up the brain. Arch Neurol1999;56:1322—1323.
25.
North K.: Neurofibromatosis type 1. Am J Med Genet2000 ;97: 119—127.
26.
Duffner PK, Cohen ME, Seidel FG, Shucard DW: The significance of MRI abnormalities in children with neurofibromatosis. Neurology1989;39:373—378.
27.
Hofman KJ, Harris EL, Bryon RN, Denckla MB: Neurofibromatosis type 1: The cognitive phenotype. J Pediatr1994;124(4):S1—S8.
28.
Wang PY, Kaufmann WE, Koth CW, et al: Thalamic involvement in neurofibromatosis type 1: Evaluation with proton magnetic resonance spectroscopic imaging. Ann Neurol2000;47:477—484.
29.
Schlag J., Schlag-Rey M.: Role of the central thalamus in gaze control. Prog Brain Res1986;64:191—201.
30.
Costa RM, Federov NB, Kogan JH, et al: Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature2002;415:526—530.
31.
Ross RG, Hommer D., Breiger D., et al: Eye movement task related to frontal lobe functioning in children with attention deficit disorder. J Am Acad Child Adolesc Psychiatry1994;33:869—874.
32.
Munoz DP, Hampton KA, Moore KD, Goldring JE: Control of purposive saccadic eye movements and visual fixation in children with attention-deficit hyperactivity disorder, in Becker W, Deubel H, Merger T (eds): Current Oculomotor Research: Physiological and Psychological Aspects. New York, Plenum, 1999, 415—423.
33.
Ross RG, Harris JG, Olincy A., Radant A.: Eye movement task measures inhibition and spatial working memory in adults with schizophrenia, ADHD, and a normal comparison group. Psychiatry Res2000;95:35—42.
34.
Mostofsky SH , Lasker AG, Cutting LE, et al: Oculomotor abnormalities in attention deficit hyperactivity disorder: A preliminary study. Neurology2001;57:423—430.
35.
Klein C., Fischer B Jr, Fischer B., Hartnegg K.: Effects of methylphenidate on saccadic responses in patients with ADHD. Exp Brain Res2002;145:121—125.
36.
Broerse A., Crawford TJ, den Boer JA: Parsing cognition in schizophrenia using saccadic eye movements: A selective overview. Neuropsychologia2001;39:742—756.
